Shares of Indian IT outsourcing giants Infosys Ltd., HCL Technologies Ltd. and Wipro Ltd. got a boost from Donald Trump’s US ...

The retail sector delivered a mixed performance during the festive season, with select pockets emerging as bright spots, ...

TCS valuations stay attractive compared with peers Infosys Ltd and HCL Technologies Ltd, analysts said as they suggested 'Buy ...

Nuvama assigned a target price of Rs 1,553 per share on Dr. Reddy's stock, implying an upside of 14.8% from the previous ...

Fifteen companies are set to announce Q3 earnings on Friday, with Just Dial and CESC Ltd expected to show notable growth.

The surge in Dr. Reddy's share followed an upgrade by domestic brokerage Nuvama, which raised its rating on the stock to 'Buy ...

Dr Reddy’s share price rose nearly 4% after Nuvama Institutional Equities upgraded its rating to ’Buy’ with a target of ...

JM Financial forecasts Jio’s ARPU to rise 4.5% QoQ to ₹204. Bharti Airtel is expected to see 4.8% QoQ growth in India ...

Nomura, on January 6, upgraded SBI Card share to ‘Buy’ from ‘Reduce’ on rising share of top metro cities in its new card ...

The Indian economy has seen a sharp slowdown, with real GDP growth falling from 8.2 per cent in FY24 to 6 per cent in the first half of FY25. The report highlights a convergence in real and nominal ...

Media companies are likely to report a subdued performance in the upcoming Q3FY25 results, according to a report by Nuvama.

Multi-Manager ICVC also sold 4.35 lakh shares or 0.52 percent stake in Dr Lal PathLabs at Rs 2,997.11 per share.